Role of chromium supplementation in Indians with type 2 diabetes mellitus

Journal of Nutritional Biochemistry

Volumn 13, Issue 11, 2002, Pages 690-697

  Ghosh, Debjani ^a   Bhattacharya, Basudev ^a   Mukherjee, Biswajit ^b   Manna, Byomkesh ^c   Sinha, Mitali ^a   Chowdhury, Jyothi ^a   Chowdhury, Subhankar ^d  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b Natural Resources Data Management System India   (India)

^c NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^d INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chromium; Glycaemic control; Lipid parameters; Picolinate

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CHROMIUM PICOLINATE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD DISEASE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DIET RESTRICTION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGY; HEMOGLOBIN DETERMINATION; HUMAN; INDIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIVER TOXICITY; MALE; MEDICAL EXAMINATION; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; POSTPRANDIAL STATE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

EID: 0036850643     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(02)00220-6     Document Type: Article

References (98)

1. Flachuk K.M. Disturbances in Trace Elements: Harrison's Principles of Internal Medicine. 14th Ed. 1998;490-491 McGraw Hill, NY.
2. Iyengar V., Woittiez J. Trace elements in human clinical specimens evaluation of literature data to identify references value . Clin Chem. 34:1988;474-481.
3. Ravina A., Slezack L. The clinical use of the trace element Cr (III) in the treatment of diabetes mellitus. Harefuah. 125:1993;142-148.
4. Cupo D.Y., Waterhahn K.E. Binding of chromium to chromatin and DNA from liver and kidneys of rats treated with sodium dichromate and chromium (III) chloride in vivo. Cancer Res. 45:1985;1146-1151.
5. Hathcock J.N. Safety limits for nutrients. J Nutr. 126:(Suppl):1996;2386-2389.
6. Bagchi D., Bagchi M., Belmoori J., et al. Comparative induction of oxidative stress in cultured J77 4 A t macrophage cells by chromium picolinate and chromium nicotinate. Res Commun Mol Pathol Pharmacol. 97:1997;335-340.
7. Baruthio F. Toxic effects of chromium and its compounds. Biol Trace Elem Res. 32:1992;145-153.
8. International Agency for Research on Cancer . Monographs on the Evolution of Carcinogenic Risks in Humans. Chromium, Nickel and Welding. 49:1990;19-527 World Health Organization.
9. Stohs S.J., Bagchi D. Oxidative mechanism in the toxicity of metal ions. Free Radic Biol Med. 18:1995;321-336.
10. Morris B.W., Griffith H., Kemp G.J. Correlations between abnormalities in chromium and glucose metabolism in a group of diabetics. Clin Chem. 34:1988;1525-1526.
11. UK Prospective Diabetic Study Group . UK prospective diabetic study XII, Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabetic Med. 11:1994;670-677.
12. Morris R.M., Griffith H., Kemp G.J., Wallch S. Clinical and biochemical aspects of chromium deficiency. J Am Coll Nutr. 4:1984;107-120.
13. Jeejeebhoy K.N., Chu R.C., Marliss E.B., Greenberg G.R., Robertson A.S. Bruce. Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 30:1977;531-538.
14. Freund H., Atamian S., Fischer J.E. Chromium deficiency during total parenteral nutrition. JAMA. 241:1979;496-498.
15. Brown R.O., Forloines-Lynx S., Cross R.E., Heizer W.D. Chromium deficiency after long term total parenteral nutrition. Dig Dis Sci. 31:1986;661-664.
16. Anderson R.A. Essentiality of chromium in humans. Sci Total Environ. 86:1989;75-81.
17. Hopkins L.L. Jr, Ransome-Kuti O., Majaj A.S. Improvement of impaired carbohydrate metabolism by chromium (III) in malnourished infants. Am J Clin Nutr. 21:1968;203-211.
18. Offenbacher E.G., Pi-Sunejer F.X. Beneficial effect of chromium rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes. 29:1980;919-925.
19. Cheng N., Jiang G., Xiou X., Hu X., Zhao Z., et al. The effects of high and low chromium yeast supplementation on glucose metabolism of non-insulin dependent diabetic patients. Presented at trace element metabolism man and animal . 1987;6th Pacific Grove, CA.
20. Nath R., Minocha J., Lyall V., Sunder S., Kumar V., Kapoor S., Dhar K.L. Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels. Shapcott D., Hubert J., Chromium in Nutrition and Metabolism. 14. 1979;Elsevier, Amsterdam.
21. Anderson R.A., Polansky M.M., Bryden N.A., Roginski E.E., Mertz W., Glinsmann W.H. Chromium supplementation of human subjects effects on glucose, insulin and lipid parameters . Metabolism. 32:1983;894-899.
22. Lipid Research Clinics Program . The Lipid Research Clinics Coronary Primary Prevention Trial results - I. Reduction in incidence of coronary artery disease. JAMA. 251:1984;351-364.
23. Lipid Research Clinics Program . The Lipid Research Clinics Coronary Primary Prevention Trial results - II. The relationship of reduction in incidence of coronary heart diseases to cholesterol lowering. JAMA. 251:1984;. 365-37.
24. Abraham A.J., Sonnerblich M., Eini M., et al. The effect of chromium on established atherosclerotic plaques in rabbit. Am J Clin Nutr. 33:1980;2294-2298.
25. Rabinowitz M.B., Gonick H.C., Levin S.R., Davidson M.B. Effects of chromium and yeast supplementation on carbohydrate and lipid metabolism in diabetic men. Biol Trace Elem Res. 5:1983;449-486.
26. Anderson R.A. Chromium metabolism and its role in disease processes in man. Clin Phys Biochem. 4:1986;31-41.
27. Toepfer E.W., Mertz W., Polansky M.W., et al. Preparation of chromium-containing material of glucose tolerance factor activity from Brewer's yeast extracts and by synthesis. J Agric Food Chem. 25:1977;162-166.
28. Mertz W., Roginski E.E. Chromium metabolism the glucose tolerance factors . Am J Clin Nutr. 33:1971;163-239.
29. Kozlovsky A.S., Moser P.B., Reiser S., Anderson R.A. Effect of diets high in simple sugars on urinary chromium losses. Metabolism. 35:1985;515-518.
30. Borel J.S., Marjerus T.C., Polansky M.M., Moser P.B., Anderson R.A. Chromium intake and urinary chromium excretion of trauma patients. Biol Trace Elem Res. 6:1984;317-326.
31. Sargent T. III, Lim T.H., Jensen R.L. Reduced chromium retention in patients with haemochromatosis a possible basis of haemochromatotic diabetes . Metabolism. 28:1979;70-79.
32. 2-carboxyl atopyridine-O,O) triaquatrichromium (III) perchlorates. Inorganica Chemica Acta. 141:1988;41-47.
33. Evans G.W., Pouchnik D.J. Composition and biological activity of chromium- pyridine carboxylate complexes. J Inorg Biochem. 49:1993;177-187.
34. Evans G.W., Bowman T.D. Chromium picolinate increases membrane fluidity and rate of insulin internalization. J Inorg Biochem. 46:1992;243-250.
35. Votava H.J., Hahn C.J., Evans G.W. Isolation and partial characterization of a chromium complex from brewer's yeast. Biochem Biophys Res Commun. 55:1973;312-319.
36. Cousins R.J. Regulatory aspects of zinc metabolism in liver and intestine. Nutr Rev. 37:1979;97-103.
37. Evans G.W., Johnson P.E. Characterization and quantitation of Zinc binding ligand in human milk. Paediatr Res. 14:1980;876-880.
38. Evans G.W. Chromium picolinate. 1996;51-57 Avery Publishing Group, New York.
39. Davies C.M., Vincent J.B. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry. 15:1997;4382-4385.
40. Vincent J.B. Mechanisms of chromium action low molecular weight, chromium binding substances . J Am Cell Nutr. 18:1999;6-12.
41. Yamamato A., Wada O., Ono T. Distribution and chromium binding capacity of a low molecular weight chromium binding substance in mice. J Inorg Biochem. 22:1984;91-102.
42. Yamamato A., Wada O., Manabe S. Evidence that chromium is an essential factor for biological activity of low-molecular weight, chromium binding substance. Biochem Biophys Res Commun. 163:1989;189-193.
43. Davies C.M., Vincent J.B. Isolation and characterization of a biologically active form of chromium oligopeptide from bovine liver. Arch Biochem Biophys. 339:1997;335-343.
44. Davies C.M., Vincent J.B. Chromium in carbohydrate and lipid metabolism. J Biol Inorg Chem. 2:1997;675-679.
45. 6 to LMWCr. J Biol Inorg Chem. 5:2000;129-130.
46. Vincent J.B. Elucidating a role for chromium at a molecular level. Accounts of Chemical Res. 33. 2000;. (in press).
47. Morris B.W., Macneil S., Hardisty C.A., et al. Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol. 13:1999;57-81.
48. - decreases plasma cholesterol and triglycerides in rats; towards chromium containing therapeutics. J Biol Inorg Chem. 6:1999;838-845.
49. - do not cleave DNA under physiologically relevant conditions. Polyhedron. 18:1999;2617-2624.
50. Norbert W., Tietz W., Clinical guide to laboratory tests. 2nd ed:1990;130 W.B. Saunders Company, USA.
51. Evenson M.E. Photometry. Burtes C.A., Ashwood E.R., Tietz Text Book of Clinical Chemistry. 2nd Ed:1994;104-131 W.B. Saunders Company, Philadelphia.
52. Stavin W. Atomic absorption spectrophotometry the present and the future . Anal Chem. 54:1982;685A-694A.
53. Klenk D.C., Hermanson G.T., Krohn R.I., et al. Determination of glycosylated hemoglobin by affinity chromatography comparison with colorimetric and ion-exchange methods, and effects of common. interferences . Clin Chem. 28:1982;2088-2094.
54. Cooper G.R., Duncan P.H., Hazelhurst J.S., et al. Cholesterol, enzymatic method. Faulkner W.R., Meites S., Selected methods of clinical chemistry. Vol. 9:1982;165-174 American Association of Clinical Chemists, Washington, D.C.
55. Naito H.K., Gatanlis V.J., Galen R.S. The measurement of serum triacylglycerol on the Hitachi 705 chemistry analyzer. Clin Chem. 31:1985;948.
56. -3. Clin Chem. 30:1984;839-842.
57. Assmann G., Jabs H.-U., Kohnert U., Nolte W., Schriewer H. LDL-cholesterol determination in blood serum following precipitation of LDL with Polyvinyl 37 sulfate. Clinca Chimica Acta. 140:1984;77-83.
58. Spencer K. Analytical reviews in clinical Biochemistry the estimation of creatinine . Ann Clin Biochem. 23:1986;1.
59. Lespinas F., Dupuy G., Aubry C. Enzymatic urea assay a new colorimetric method based on hydrogen peroxide measurement . Clin Chem. 35:1989;654-658.
60. IFCC Part 3, Method for alanine aminotransferase. Clin. Chem. Acta. 105:1979;F147-F172.
61. IFCC Part 5, Method for alkaline phosphatase. Clin Chem Acta. 136:1983b;F339-F3.
62. Schwarz K., Mertz W. A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys. 72:1957;515-518.
63. Schwarz K., Mertz W. Chromium III and the glucose tolerance factor. Arch Biochem Biophys. 85:1959;292-296.
64. Wooliseraft J., Babosa J. Analysis of chromium induced carbohydrate intolerance in the rat. J Nutr. 107:1977;1702-1706.
65. Tuman R.W., Bilbo J.T., Doisy R.J. Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice. Diabetes. 27:1978;49-56.
66. Davidson I.W.F., Blackwell W.L. Change in carbohydrate metabolism of squirrel monkeys with chromium dietary supplementation. Proc Soc Exp Med Biol. 127:1968;66-70.
67. Mertz W. Chromium occurrence and function in biological systems. Physiol Rev. 49:1969;163-203.
68. Doisy R.J., Streeten D.H.P., Freiberg T.M., Schneider A.J. Chromium metabolism in man and biological effects. Prasad A.S., Oberleas D., Trace Elements in Human Health and Disease. Vol. II:1976;79-104 Academic Press, New York.
69. Riales R. Influence of brewer's yeast on lipoprotein cholesterol concentration - a preliminary report. Shapcott D., Hubert J., Chromium in Nutrition and Metabolism. 1979;199-212 Elsevier/North Holland Biochemical Press, Amsterdam.
70. Press R.J., Geller J., Evans G.W. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med. 152:1990;41-45.
71. Mark F., McCarty B.A. The case for supplemental chromium and a survey of clinical studies with chromium picolinate. J Appl Nutr. 4:(1):1991;58-66.
72. Evans G.W. The role of picolinic acid in metal metabolism. Life Chem Res. 1:1982;57-67.
73. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Chang N., Chi J., Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 46:(II):1997;1786-1791.
74. Lienhard G.E., Slot J.W., Mueckler M.M. How cells absorb glucose. Scientific Am J. 226:1992;86-91.
75. Wasser W.G., Feldman N.S., D'Agati V.D. Chronic renal failure after ingestion of over the counter chromium picolinate. (letter) Ann Intern Med. 126:1997;410.
76. Cerulli J., Grabe D.W., Gauthier I., et al. Chromium picolinate toxicity. Ann Pharmacother. 32:1998;. 438-431.
77. Harris M.I., Hadden W.C., Knowler W.C., Bennett P.H. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 years. Diabetes. 36:1987;523-534.
78. Shanghai Diabetic Research Co-Operative Group . Diabetes mellitus survey in Shanghai. Clin Med J. 93:1980;663-672.
79. Flegal K.M., Ezzati T.M., Harris M.I., et al. Prevalence of diabetes in Latin American Countries 1982-84. Diabetes Care. 14:1991;628-638.
80. Anderson D.K.G., Svardsudd K., Tibblin G. Prevalence of diabetes in a Swedish community 1972-1987. Diabetic Med. 8:1987;428-434.
81. Erikson, et al. Risks of developing Type 2 diabetes mellitus. Diabetologia. 34:1991;192-197.
82. Chan J.M., et al. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 17:1994;961-969.
83. Schroeder H.A. Losses of vitamins and trace minerals resulting from processing and preservation of foods. Am J Clin Nutr. 24:1971;562-573.
84. Diabetes Epidemiology Research International . Preventing insulin dependent diabetes mellitus the environmental challenge . Br Med J. 295:1987;479-481.
85. Tipton I.H., Schroeder H.A., Perry H.M. Jr, Cook M.J. Trace elements in human tissue III. Subjects from Africa, the near and far East and Europe. Health Phys. 11:1965;403-451.
86. Subramanyam G., Vijaya J., Chandrasekhar P., Rameshbabu C.D., Ramakrishna M.V. Serum trace metal analysis in relation to lipid profile and glucose of industrial workers at Ranipet. Ind J Clin Prac. 5:(12):1995;34-44.
87. Lim T.H., Sargent T. III, Kusulov N. Kinetics of trace element chromium (III) in the human body. Am J Physiol. 244:1983;445-454.
88. Davies S., McLaren H.J., Hunniset A., Howard M. Age related decrease in chromium levels in 51,665 hair, sweat and serum samples from 40,872 patients - implications for the prevention of vascular disease and type 2 diabetes mellitus. Metabolism. 46:(5):1997;469-473.
89. Vincent J.B. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev. 58:(3):2000;67-72.
90. Glinsmann W.H., Mertz W. Effect of trivalent chromium on glucose tolerance. Metabolism. 15:1966;510-520.
91. Mossop R.T. Effects of chromium(III) on fasting glucose, cholesterol and cholesterol HDL levels in diabetics. Cent Africa J Med. 29:1983;80-82.
92. Kimura K. Role of essential trace elements in the disturbance of carbohydrate metabolism. Nippon Rinsho. 54:(1):1996;79-84.
93. Thomas V.L., Gropper S.S. Effect of chromium and nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol Trace Res. 55:(3):1996;297-305.
94. Abraham A.S., Brooks B.A., Eylath U. Chromium and cholesterol induced atherosclerosis in rabbits. Ann Nutr Metab. 35:1991;203-207.
95. Lee N.A., Reasner C.A. Beneficial effects of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 17:1994;1449-1452.
96. Offenbacher E.G., Rinko C.J., Pi-Sunyer F.X. The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids and plasma chromium in elderly subjects. Am J Clin Nutr. 42:1985;454-461.
97. Bukowski J.A., Goldstein M.D., Johnson B.B. Biological markers in chromium exposure assessment confounding variables. Arch. Environ. Health. 46:1991;230-236.
98. Lukaski H.C. Chromium as a supplement. Ann Rev Nutr. 19:1999;279-301.